Found: 50
Select item for more details and to access through your institution.
Value of autotaxin for hepatocellular carcinoma risk assessment in chronic hepatitis B patients treated with nucleos(t)ide analogs.
- Published in:
- Hepatology Research, 2024, v. 54, n. 11, p. 981, doi. 10.1111/hepr.14042
- By:
- Publication type:
- Article
Identification and monitoring of mutations in circulating cell-free tumor DNA in hepatocellular carcinoma treated with lenvatinib.
- Published in:
- Journal of Experimental & Clinical Cancer Research (17569966), 2021, v. 40, n. 1, p. 1, doi. 10.1186/s13046-021-02016-3
- By:
- Publication type:
- Article
Increasing incidence of non-HBV- and non-HCV-related hepatocellular carcinoma: single-institution 20-year study.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Clinical Outcomes of Switching from Zoledronic Acid to Denosumab for the Management of Severe Bone Metastasis from Hepatocellular Carcinoma: A Single-Center, Open-Label, Prospective Intervention Trial.
- Published in:
- Yonago Acta Medica, 2023, v. 66, n. 4, p. 422, doi. 10.33160/yam.2023.11.007
- By:
- Publication type:
- Article
Successful Lenvatinib Re-challenge following Atezolizumab Plus Bevacizumab Combination Therapy Failure for Unresectable Hepatocellular Carcinoma.
- Published in:
- Internal Medicine, 2023, v. 62, n. 12, p. 1771, doi. 10.2169/internalmedicine.9581-22
- By:
- Publication type:
- Article
Hepatic venous pressure gradient after balloon-occluded retrograde transvenous obliteration and liver stiffness measurement predict the prognosis of patients with gastric varices.
- Published in:
- BMC Gastroenterology, 2022, v. 22, n. 1, p. 1, doi. 10.1186/s12876-022-02616-z
- By:
- Publication type:
- Article
Efficacy and safety of chemoradiation therapy using one-shot cisplatin via hepatic arterial infusion for advanced hepatocellular carcinoma with major macrovascular invasion: a single-arm retrospective cohort study.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Reply from the authors.
- Published in:
- Hepatology Research, 2020, v. 50, n. 12, p. 1393, doi. 10.1111/hepr.13578
- By:
- Publication type:
- Article
Incidence of microsatellite instability‐high hepatocellular carcinoma among Japanese patients and response to pembrolizumab.
- Published in:
- Hepatology Research, 2020, v. 50, n. 7, p. 885, doi. 10.1111/hepr.13496
- By:
- Publication type:
- Article
Comparison of hepatic arterial infusion chemotherapy between 5‐fluorouracil‐based continuous infusion chemotherapy and low‐dose cisplatin monotherapy for advanced hepatocellular carcinoma.
- Published in:
- Hepatology Research, 2018, v. 48, n. 13, p. 1118, doi. 10.1111/hepr.13232
- By:
- Publication type:
- Article
Clinical outcomes of sorafenib treatment failure for advanced hepatocellular carcinoma and candidates for regorafenib treatment in real‐world practice.
- Published in:
- Hepatology Research, 2018, v. 48, n. 10, p. 814, doi. 10.1111/hepr.13180
- By:
- Publication type:
- Article
Peripheral T Cell Subpopulations as a Potential Surrogate Biomarker during Atezolizumab plus Bevacizumab Treatment for Hepatocellular Carcinoma.
- Published in:
- Cancers, 2024, v. 16, n. 7, p. 1328, doi. 10.3390/cancers16071328
- By:
- Publication type:
- Article
Therapeutic Efficacy and Safety of Lenvatinib after Atezolizumab Plus Bevacizumab for Unresectable Hepatocellular Carcinoma.
- Published in:
- Cancers, 2023, v. 15, n. 22, p. 5406, doi. 10.3390/cancers15225406
- By:
- Publication type:
- Article
Association of Hepatobiliary Phase of Gadoxetic-Acid-Enhanced MRI Imaging with Immune Microenvironment and Response to Atezolizumab Plus Bevacizumab Treatment.
- Published in:
- Cancers, 2023, v. 15, n. 17, p. 4234, doi. 10.3390/cancers15174234
- By:
- Publication type:
- Article
Evaluation of Response to Atezolizumab Plus Bevacizumab in Patients with Advanced Hepatocellular Carcinoma Using the Combination of Response Evaluation Criteria in Solid Tumors and Alpha-Fetoprotein.
- Published in:
- Cancers, 2023, v. 15, n. 8, p. 2304, doi. 10.3390/cancers15082304
- By:
- Publication type:
- Article
Effectiveness of Repeated Stereotactic Body Radiation Therapy for Hepatocellular Carcinoma—Consideration of the Locations of Target Lesions.
- Published in:
- Cancers, 2023, v. 15, n. 3, p. 846, doi. 10.3390/cancers15030846
- By:
- Publication type:
- Article
Analysis of Lenvatinib's Efficacy against Intermediate-Stage Unresectable Hepatocellular Carcinoma.
- Published in:
- Cancers, 2022, v. 14, n. 20, p. 5066, doi. 10.3390/cancers14205066
- By:
- Publication type:
- Article
Analysis of Survival and Response to Lenvatinib in Unresectable Hepatocellular Carcinoma.
- Published in:
- Cancers, 2022, v. 14, n. 2, p. 320, doi. 10.3390/cancers14020320
- By:
- Publication type:
- Article
Early Tumor Response and Safety of Atezolizumab Plus Bevacizumab for Patients with Unresectable Hepatocellular Carcinoma in Real-World Practice.
- Published in:
- Cancers, 2021, v. 13, n. 16, p. 3958, doi. 10.3390/cancers13163958
- By:
- Publication type:
- Article
Skeletal Muscle Volume Is an Independent Predictor of Survival after Sorafenib Treatment Failure for Hepatocellular Carcinoma.
- Published in:
- Cancers, 2021, v. 13, n. 9, p. 2247, doi. 10.3390/cancers13092247
- By:
- Publication type:
- Article
Risk Factors for Early Onset of Proteinuria in Patients Receiving Atezolizumab Plus Bevacizumab for Unresectable Hepatocellular Carcinoma.
- Published in:
- Liver Cancer (2235-1795), 2023, v. 12, n. 3, p. 251, doi. 10.1159/000528145
- By:
- Publication type:
- Article
Management of Systemic Therapies and Hepatic Arterial Infusion Chemotherapy in Patients with Advanced Hepatocellular Carcinoma Based on Sarcopenia Assessment.
- Published in:
- Liver Cancer (2235-1795), 2022, v. 11, n. 4, p. 329, doi. 10.1159/000522389
- By:
- Publication type:
- Article
Pathological Complete Response to Lenvatinib after Failure of Atezolizumab plus Bevacizumab in Unresectable Hepatocellular Carcinoma.
- Published in:
- 2022
- By:
- Publication type:
- Case Study
Hepatic Arterial Infusion Chemotherapy Combined with Radiation Therapy for Advanced Hepatocellular Carcinoma with Tumor Thrombosis of the Main Trunk or Bilobar of the Portal Vein.
- Published in:
- Liver Cancer (2235-1795), 2021, v. 10, n. 2, p. 151, doi. 10.1159/000513706
- By:
- Publication type:
- Article
Efficacy and safety of atezolizumab plus bevacizumab in patients with portal hypertension for unresectable hepatocellular carcinoma.
- Published in:
- Cancer Medicine, 2024, v. 13, n. 5, p. 1, doi. 10.1002/cam4.7025
- By:
- Publication type:
- Article
Impact of skeletal muscle volume on patients with BCLC stage‐B hepatocellular carcinoma undergoing sorafenib therapy.
- Published in:
- Cancer Medicine, 2023, v. 12, n. 9, p. 10625, doi. 10.1002/cam4.5810
- By:
- Publication type:
- Article
Early changes in ammonia levels and liver function in patients with advanced hepatocellular carcinoma treated by lenvatinib therapy.
- Published in:
- Scientific Reports, 2019, v. 9, n. 1, p. N.PAG, doi. 10.1038/s41598-019-48045-z
- By:
- Publication type:
- Article
Correlation between serum pro‐inflammatory cytokine levels and the prognosis of the patients with acute liver failure.
- Published in:
- Journal of Gastroenterology & Hepatology, 2023, v. 38, n. 9, p. 1637, doi. 10.1111/jgh.16300
- By:
- Publication type:
- Article
Underestimation of impaired glucose tolerance and usefulness of a continuous glucose monitoring system in chronic liver disease.
- Published in:
- Journal of Gastroenterology & Hepatology, 2022, v. 37, n. 3, p. 592, doi. 10.1111/jgh.15766
- By:
- Publication type:
- Article
Extracellular water to total body water ratio obtained by bioelectrical impedance analysis determines the dose intensity of lenvatinib for the treatment of patients with advanced hepatocellular carcinoma.
- Published in:
- Journal of Gastroenterology & Hepatology, 2021, v. 36, n. 6, p. 1685, doi. 10.1111/jgh.15377
- By:
- Publication type:
- Article
The presence of vessels encapsulating tumor clusters is associated with an immunosuppressive tumor microenvironment in hepatocellular carcinoma.
- Published in:
- International Journal of Cancer, 2022, v. 151, n. 12, p. 2278, doi. 10.1002/ijc.34247
- By:
- Publication type:
- Article
Early experience of seven hepatocellular carcinoma cases treated with regorafenib.
- Published in:
- 2018
- By:
- Publication type:
- Case Study
Benign Recurrent Intrahepatic Cholestasis Type 1 with Novel Nonsense Mutations in the ATP8B1 Gene.
- Published in:
- 2022
- By:
- Publication type:
- Case Study
Calcium channel blockers improve the prognosis of patients with intrahepatic cholangiocarcinoma after resection.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Management of refractory ascites attenuates muscle mass reduction and improves survival in patients with decompensated cirrhosis.
- Published in:
- 2020
- By:
- Publication type:
- journal article
The importance of body composition assessment for patients with advanced hepatocellular carcinoma by bioelectrical impedance analysis in lenvatinib treatment.
- Published in:
- PLoS ONE, 2022, v. 17, n. 1, p. 1, doi. 10.1371/journal.pone.0262675
- By:
- Publication type:
- Article
Outcomes of Patients with Child-Pugh B and Unresectable Hepatocellular Carcinoma Undergoing First-Line Systemic Treatment with Sorafenib, Lenvatinib, or Atezolizumab Plus Bevacizumab.
- Published in:
- Oncology, 2024, v. 102, n. 3, p. 239, doi. 10.1159/000533859
- By:
- Publication type:
- Article
The Analysis of Muscle Volume Measured by Bioelectrical Impedance in Patients with Hepatocellular Carcinoma Treated with First-Line Atezolizumab plus Bevacizumab Combination Therapy or First-Line Lenvatinib.
- Published in:
- Oncology, 2023, v. 101, n. 8, p. 491, doi. 10.1159/000530991
- By:
- Publication type:
- Article
Efficacy and Safety of Lenvatinib-Transcatheter Arterial Chemoembolization Sequential Therapy for Patients with Intermediate-Stage Hepatocellular Carcinoma.
- Published in:
- Oncology, 2021, v. 99, n. 8, p. 507, doi. 10.1159/000515865
- By:
- Publication type:
- Article
Clinical Outcomes of 2nd- and 3rd-Line Regorafenib for Advanced Hepatocellular Carcinoma.
- Published in:
- Oncology, 2021, v. 99, n. 8, p. 491, doi. 10.1159/000515280
- By:
- Publication type:
- Article
Comparison of the Clinical Outcome of Ramucirumab for Unresectable Hepatocellular Carcinoma with That of Prior Tyrosine Kinase Inhibitor Therapy.
- Published in:
- Oncology, 2021, v. 99, n. 5, p. 327, doi. 10.1159/000514315
- By:
- Publication type:
- Article
Analysis of Post-Progression Survival in Patients with Unresectable Hepatocellular Carcinoma Treated with Lenvatinib.
- Published in:
- Oncology, 2020, v. 98, n. 11, p. 787, doi. 10.1159/000509387
- By:
- Publication type:
- Article
Trends in Hepatic Functional Reserve of Patients with Hepatocellular Carcinoma Treated with Tyrosine Kinase Inhibitors.
- Published in:
- Oncology, 2020, v. 98, n. 10, p. 727, doi. 10.1159/000507815
- By:
- Publication type:
- Article
Correlation between Early Tumor Marker Response and Imaging Response in Patients with Advanced Hepatocellular Carcinoma Treated with Lenvatinib.
- Published in:
- Oncology, 2019, v. 97, n. 2, p. 75, doi. 10.1159/000499715
- By:
- Publication type:
- Article
Comparison of Outcome of Hepatic Arterial Infusion Chemotherapy Combined with Radiotherapy and Sorafenib for Advanced Hepatocellular Carcinoma Patients with Major Portal Vein Tumor Thrombosis.
- Published in:
- Oncology, 2018, v. 94, n. 4, p. 215, doi. 10.1159/000486483
- By:
- Publication type:
- Article
The Hepatitis B Virus PreS1/HBsAg Ratio Is a Predictive Marker for the Occurrence of Hepatocellular Carcinoma.
- Published in:
- Livers, 2024, v. 4, n. 3, p. 364, doi. 10.3390/livers4030026
- By:
- Publication type:
- Article
Useful Predictor for Exacerbation of Esophagogastric Varices after Hepatitis C Virus Eradication by Direct-Acting Antivirals.
- Published in:
- Livers, 2024, v. 4, n. 3, p. 352, doi. 10.3390/livers4030025
- By:
- Publication type:
- Article
Risk factors for histological progression of non‐alcoholic steatohepatitis analyzed from repeated biopsy cases.
- Published in:
- Journal of Gastroenterology & Hepatology, 2020, v. 35, n. 8, p. 1412, doi. 10.1111/jgh.14968
- By:
- Publication type:
- Article
Comparison of clinical outcome of hepatic arterial infusion chemotherapy and sorafenib for advanced hepatocellular carcinoma according to macrovascular invasion and transcatheter arterial chemoembolization refractory status.
- Published in:
- Journal of Gastroenterology & Hepatology, 2018, v. 33, n. 10, p. 1780, doi. 10.1111/jgh.14152
- By:
- Publication type:
- Article
Impact and usefulness of the transition to the new MAFLD classification for non-B, non-C HCC: a retrospective cohort study.
- Published in:
- BMC Gastroenterology, 2023, v. 23, n. 1, p. 1, doi. 10.1186/s12876-023-02851-y
- By:
- Publication type:
- Article